GOCOVRI™ (amantadine) extended release capsules
GOCOVRI™ (amantadine) extended release capsules is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy, with or without dopaminergic medications.

For full prescribing information, visit

Partnered Product
NAMZARIC® (memantine HCl and donepezil HCl) extended-release capsules
NAMZARIC is marketed by Allergan plc pursuant to an exclusive license agreement between Forest Laboratories Holdings Limited, an indirect wholly owned subsidiary of Allergan plc and Adamas Pharmaceuticals, Inc.

Visit for more details.